Anhui Provincial Hospital: clinical-trial pipeline
Anhui Provincial Hospital is the sponsor of 131 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 72 are not yet finished and 6 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 62 |
| Phase 2 | 24 |
| Early phase 1 | 14 |
| Phase 1 | 14 |
| Phase 4 | 8 |
| Phase 3 | 5 |
| Phase 1/2 | 4 |
Trials by status
| Status | Trials |
|---|---|
| Unknown | 47 |
| Recruiting | 45 |
| Not yet recruiting | 24 |
| Completed | 12 |
| Active, not recruiting | 3 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 76 |
| Gastroenterology and liver | 23 |
| Women's health and obstetrics | 16 |
| Nephrology and urology | 13 |
| Haematology | 12 |
| Neurology | 8 |
| Immunology and rheumatology | 7 |
| Cardiovascular | 6 |
| Infectious disease and vaccines | 3 |
| Metabolic and endocrine (diabetes, obesity) | 3 |
| Dermatology | 2 |
| Musculoskeletal | 2 |
Countries
| Country | Trials |
|---|---|
| China | 104 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-21 | New trial posted | Conditioning Regimen Containing Low-Dose ATG for the Treatment of AA Receiving sUCBT |
| 2026-09-25 | New trial posted | Zanidatamab Combined With Liposomal Irinotecan and Capecitabine for Second-line Treatment… |
| 2026-09-21 | New trial posted | Multimodal Survival Prediction Model for Colorectal Liver Metastases Post-Operation |
| 2026-09-11 | New trial posted | External Transportability Validation, Implementation Readiness, and Outcome Association o… |
| 2026-09-10 | New trial posted | Perioperative Adebrelimab for Locally Advanced Cervical Cancer |
| 2026-08-28 | New trial posted | Oral Zinc Supplementation Combined With Targeted Immunotherapy for Unresectable or Advanc… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT06898983 | Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Trea… | Phase 2 | Recruiting | China |
| NCT06602843 | Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy | Not applicable | Recruiting | China |
| NCT07106814 | Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of A… | Early phase 1 | Recruiting | China |
| NCT07150624 | The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine | Phase 4 | Recruiting | China |
| NCT07811375 | Perioperative Adebrelimab for Locally Advanced Cervical Cancer | Phase 2 | Not yet recruiting | China |
| NCT06777485 | China Liver Cancer Clinical Registry Cohort Database (HEAL) | Not applicable | Recruiting | China |
| NCT07131085 | QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS) | Phase 1 | Not yet recruiting | |
| NCT07231770 | Sulfamethoxazole Prophylaxis Duration After Renal Transplantation | Not applicable | Recruiting | China |
| NCT07211048 | Anti CD19 Gene Therapy for B-cell Lymphoma | Not applicable | Recruiting | China |
| NCT07120607 | Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia | Phase 1 | Not yet recruiting | |
| NCT07208344 | Intravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's Disease | Early phase 1 | Recruiting | China |
| NCT06527898 | Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer | Phase 1/2 | Recruiting | China |
| NCT06855290 | Tumor Immunity and Cancer Recurrence Prediction Model | Not applicable | Not yet recruiting | |
| NCT07098884 | Artificial Intelligence for Pathology Diagnosis and Prognosis Prediction of Lung Nodule Using Smartphone Phot… | Not applicable | Recruiting | China |
| NCT07034118 | Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal S… | Phase 1 | Not yet recruiting | China |
| NCT07077980 | Discovery of HPV T Cell Epitopes and Development of Multi-epitope Vaccines | Not applicable | Not yet recruiting | China |
| NCT06321198 | A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With… | Not applicable | Recruiting | China |
| NCT07709338 | Targeted Biopsy, Rapid Pathology, and Immediate Surgery in USTC High-Risk Prostate Cancer: A Prospective Mult… | Not applicable | Not yet recruiting | |
| NCT07481656 | Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (G… | Phase 4 | Not yet recruiting | China |
| NCT06664021 | Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With P… | Phase 2 | Recruiting | China |
| NCT06415500 | A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites | Phase 1 | Not yet recruiting | China |
| NCT06671275 | A Clinical Study to Evaluate CUD005 Injection in Patients with Liver Cirrhosis | Phase 1 | Recruiting | China |
| NCT06542549 | Efficacy and Safety of AK104 (PD-1/CTLA-4 Bispecial Antibody) Combined With Chemotherapy for Neoadjuvant Trea… | Phase 3 | Not yet recruiting | |
| NCT07085559 | Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell… | Early phase 1 | Recruiting | China |
| NCT05937438 | Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma | Phase 1/2 | Recruiting | China |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Anhui Provincial Hospital clinical trials: 72 open, 5 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/anhui-provincial-hospital/, data as of 2026-10-25.